Skip to content
akaturk Academic measurement
2025 SJR Q1 JCR Q2 · 4,6 OA 1 matched articles ESCI

Journal detail

Frontiers in Medical Technology

Publisher
Frontiers Media SA
Country
Switzerland · Western Europe
Type
journal
ISSN
  • 26733129
Scopus 0,91 SJR
Scopus Q1 SJR Q
WoS Q2 JCR Q
WoS 4,6 JIF
Scopus 29 H-Index

Integrated evaluation

Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.

WoS / JCR data covers 1997 onward.

Scopus

Scopus · Scimago

  • SJR 0,91
  • Quartile Q1
  • H-Index 29
  • Cites/doc 4,02
  • Docs (3y) 219
  • Cites (3y) 1.160

Clarivate

Web of Science · JCR · 2025

  • JCR Q Q2
  • JIF 4,6
  • 5Y JIF 4,8
  • JCI 0,57

WoS indexes

  • ESCI

Subject classification

Categories (SJR)

  • Biomedical Engineering Q2
  • Health Professions (miscellaneous) Q1
  • Medical Laboratory Technology Q1
  • Medicine (miscellaneous) Q1
  • Pharmacology (medical) Q2
  • Radiological and Ultrasound Technology Q1

Areas

  • Engineering
  • Health Professions
  • Medicine

WoS categories

  • Engineering, Biomedical

Yearly quartile comparison

Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.

WoS / JCR data covers 1997 onward.

Note: JCR Q, JIF, 5Y JIF, JCI, and JCI Q are blank before 1997 — WoS/JCR data on this site starts in 1997.
Year SJR Q JCR Q (1997+) SJR JIF (1997+) 5Y JIF (1997+) JCI (1997+) JCI Q (1997+) H-Index
2025 Q1 Q2 0,91 4,6 4,8 0,57 Q3 29
2024 Q1 Q2 0,74 3,8 4 0,5 Q3 22
2023 Q1 Q3 0,602 2,7 3,1 0,4 Q3 22
2022 22
2021 22
2020 22

JCR category quartile history

JCR / JCI quartile by year and category. 1997 and later.

WoS / JCR data covers 1997 onward.

Note: This table shows Clarivate category quartile records from 1997 onward.
Year Category Edition JCR Q (1997+) JCI Q (1997+) Rank
2025 ENGINEERING, BIOMEDICAL ESCI Q2 Q3 44/130
2024 ENGINEERING, BIOMEDICAL ESCI Q2 Q3 48/124
2023 ENGINEERING, BIOMEDICAL ESCI Q3 Q3 68/123